Alzheimer's Drug Discovery Foundation

The Alzheimer's Drug Discovery Foundation (ADDF) is a nonprofit organization founded in 1998 by Leonard A. Lauder and Ronald S. Lauder. Its core mission is to accelerate the discovery of drugs to prevent, treat, and cure Alzheimer's disease. The ADDF focuses on funding early-stage research and early-phase clinical trials that might otherwise go unfunded. The organization supports a range of programs, including preclinical drug research, clinical trials, cognitive vitality and prevention, and ADDF Access, which aims to expedite the development of effective treatments.

Notable figures affiliated with ADDF include Dr. Howard Fillit, who serves as the Executive Director and Chief Science Officer. The foundation has invested over $65 million in more than 450 programs globally. Key achievements include funding groundbreaking studies published in prestigious journals like Nature Medicine and receiving endorsements from influential figures such as Bill Gates. The ADDF's impact is significant in the Alzheimer's research community, driving innovation and hope for new treatments.